227 related articles for article (PubMed ID: 25406793)
1. Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer.
Kim IY; You SH; Kim YW
BMC Surg; 2014 Nov; 14():94. PubMed ID: 25406793
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy.
Sung S; Son SH; Park EY; Kay CS
PLoS One; 2017; 12(3):e0173955. PubMed ID: 28291841
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M
Anticancer Res; 2013 Nov; 33(11):5065-74. PubMed ID: 24222151
[TBL] [Abstract][Full Text] [Related]
4. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
[TBL] [Abstract][Full Text] [Related]
5. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
Shen L; Zhang H; Liang L; Li G; Fan M; Wu Y; Zhu J; Zhang Z
Radiat Oncol; 2014 Dec; 9():295. PubMed ID: 25518933
[TBL] [Abstract][Full Text] [Related]
6. Systemic Inflammatory Response After Preoperative Chemoradiotherapy Can Affect Oncologic Outcomes in Locally Advanced Rectal Cancer.
Lee IH; Hwang S; Lee SJ; Kang BW; Baek D; Kim HJ; Park SY; Park JS; Choi GS; Kim JC; Cho SH; Kim JG
Anticancer Res; 2017 Mar; 37(3):1459-1465. PubMed ID: 28314318
[TBL] [Abstract][Full Text] [Related]
7. The Role of Neutrophil-to-lymphocyte Ratio on the Effect of CRT for Patients With Rectal Cancer.
Ishikawa D; Nishi M; Takasu C; Kashihara H; Tokunaga T; Higashijima J; Yoshikawa K; Shimada M
In Vivo; 2020; 34(2):863-868. PubMed ID: 32111796
[TBL] [Abstract][Full Text] [Related]
8. Oncologic Outcome and Morbidity in the Elderly Rectal Cancer Patients After Preoperative Chemoradiotherapy and Total Mesorectal Excision: A Multi-institutional and Case-matched Control Study.
Sung SY; Jang HS; Kim SH; Jeong JU; Jeong S; Song JH; Chung MJ; Cho HM; Kim HJ; Kim JG; Lee IK; Lee JH
Ann Surg; 2019 Jan; 269(1):108-113. PubMed ID: 28742692
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Low Rectal Cancer Treated with Preoperative Chemoradiotherapy.
Nagasaki T; Akiyoshi T; Fujimoto Y; Konishi T; Nagayama S; Fukunaga Y; Ueno M
Dig Surg; 2015; 32(6):496-503. PubMed ID: 26544755
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
[TBL] [Abstract][Full Text] [Related]
11. Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer.
Carruthers R; Tho LM; Brown J; Kakumanu S; McCartney E; McDonald AC
Colorectal Dis; 2012 Oct; 14(10):e701-7. PubMed ID: 22731833
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of Leukocyte- and Platelet-Derived Ratios in Rectal Adenocarcinoma.
Ward WH; Goel N; Ruth KJ; Esposito AC; Lambreton F; Sigurdson ER; Meyer JE; Farma JM
J Surg Res; 2018 Dec; 232():275-282. PubMed ID: 30463730
[TBL] [Abstract][Full Text] [Related]
13. Stage-to-stage comparison of preoperative and postoperative chemoradiotherapy for T3 mid or distal rectal cancer.
Yeo SG; Kim DY; Park JW; Choi HS; Oh JH; Kim SY; Chang HJ; Kim TH; Sohn DK
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):856-62. PubMed ID: 21300482
[TBL] [Abstract][Full Text] [Related]
14. Circulating lymphocytes as predictors of sensitivity to preoperative chemoradiotherapy in rectal cancer cases.
Dou X; Wang RB; Yan HJ; Jiang SM; Meng XJ; Zhu KL; Xu XQ; Mu DB
Asian Pac J Cancer Prev; 2013; 14(6):3881-5. PubMed ID: 23886201
[TBL] [Abstract][Full Text] [Related]
15. Pre-operative Neutrophils/Lymphocyte Ratio in Rectal Cancer Patients with Preoperative Chemoradiotherapy.
Lino-Silva LS; Salcedo-Hernández RA; Ruiz-García EB; García-Pérez L; Herrera-Gómez Á
Med Arch; 2016 Jul; 70(4):256-260. PubMed ID: 27703284
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Preoperative Neutrophil-Lymphocyte Ratios in Patients with Stage I Non-small Cell Lung Cancer After Complete Resection.
Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Morita S; Kawamura M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1324-31. PubMed ID: 26198075
[TBL] [Abstract][Full Text] [Related]
17. A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer.
Shibutani M; Maeda K; Nagahara H; Noda E; Ohtani H; Nishiguchi Y; Hirakawa K
Anticancer Res; 2013 Aug; 33(8):3291-4. PubMed ID: 23898094
[TBL] [Abstract][Full Text] [Related]
18. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer.
Graziosi L; Marino E; De Angelis V; Rebonato A; Cavazzoni E; Donini A
Am J Surg; 2015 Feb; 209(2):333-7. PubMed ID: 25190544
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
Shen J; Zhu Y; Wu W; Zhang L; Ju H; Fan Y; Zhu Y; Luo J; Liu P; Zhou N; Lu K; Zhang N; Li D; Liu L
Med Sci Monit; 2017 Jan; 23():315-324. PubMed ID: 28100902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]